Position in GSK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,177,192
+$307,435 QoQ
Shares Held
79,687
+13.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#29
of 393 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ashton Thomas Private Wealth, LLC holds $137,195,168 across 14 Drug Manufacturers - General names. GSK ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
103,640 | $37,530,116 | |
| 2 | LLY |
ELI LILLY & Co
|
21,219 | $25,450,707 | |
| 3 | ABBV |
AbbVie Inc.
|
72,676 | $18,288,188 | |
| 4 | MRK |
Merck & Co., Inc.
|
120,301 | $15,458,678 | |
| 5 | JNJ |
Johnson & Johnson
|
56,610 | $14,377,241 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
62,087 | $7,844,071 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
122,267 | $7,045,024 | |
| 8 | GSK |
GSK plc
This page
|
79,687 | $4,177,192 |
All Filings in GSK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,177,192 | 79,687 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,869,757 | 70,117 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,980,700 | 60,781 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,624,732 | 60,814 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,326,464 | 60,585 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $742,064 | 19,155 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $667,640 | 19,741 | Shares | Sole | 2025-02-07 | |
| 2024-06-30 | $36,652 | 952 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||